These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 11387358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.
    Shariat SF, Kattan MW, Traxel E, Andrews B, Zhu K, Wheeler TM, Slawin KM.
    Clin Cancer Res; 2004 Mar 15; 10(6):1992-9. PubMed ID: 15041717
    [Abstract] [Full Text] [Related]

  • 6. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
    Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, Muramoto M, Scardino PT, Ohori M, Wheeler TM, Slawin KM.
    J Clin Oncol; 2003 Oct 01; 21(19):3573-9. PubMed ID: 12913106
    [Abstract] [Full Text] [Related]

  • 7. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.
    Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM.
    Urology; 2001 Dec 01; 58(6):1008-15. PubMed ID: 11744478
    [Abstract] [Full Text] [Related]

  • 8. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P, Katcher J, Levin H, Zippe C, Klein E.
    Urology; 1996 Aug 01; 48(2):249-60. PubMed ID: 8753737
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H.
    Mayo Clin Proc; 2001 Jun 01; 76(6):576-81. PubMed ID: 11393495
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy.
    Zhao Z, Ma W, Zeng G, Qi D, Ou L, Liang Y.
    Prostate; 2012 Feb 01; 72(3):270-9. PubMed ID: 21630293
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters.
    Sinnreich O, Kratzsch J, Reichenbach A, Gläser C, Huse K, Birkenmeier G.
    Prostate; 2004 Nov 01; 61(3):201-8. PubMed ID: 15368477
    [Abstract] [Full Text] [Related]

  • 19. Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer.
    Shariat SF, Bensalah K, Karam JA, Roehrborn CG, Gallina A, Lotan Y, Slawin KM, Karakiewicz PI.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5377-84. PubMed ID: 17875766
    [Abstract] [Full Text] [Related]

  • 20. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.
    Pound CR, Partin AW, Epstein JI, Walsh PC.
    Urol Clin North Am; 1997 May 15; 24(2):395-406. PubMed ID: 9126237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.